Verition Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Verition Fund Management's LLY Position: Q1 2026 in Review
Verition Fund Management reduced its Eli Lilly (LLY) stake by 42% in Q1 2026, selling an estimated $2.22M and leaving 3,008 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #858.
Verition Fund Management first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $182M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Verition Fund Management held 3,008 shares of Eli Lilly worth $2.77M as of Q1 2026.
- Verition Fund Management sold 2,185 Eli Lilly shares in Q1 2026, an estimated $2.22M.
- Eli Lilly made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #858 holding.
- Verition Fund Management first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
- Verition Fund Management's Eli Lilly position peaked at $182M in Q3 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.